Weight loss alone does not guarantee better health if muscle strength and bone density are being lost at the same time
Both Wegovy and these antidepressants can lower your blood sugar levels
Dulaglutide was approved by the US FDA and the EMA in 2014
Positive effects observed in studies include: Reduced liver fat accumulation Lower ALT and AST levels in patients with fatty liver Improved insulin sensitivity, which reduces liver workload Decreased inflammation markers Research published in The Lancet found that semaglutide significantly reduced liver fat and improved fibrosis markers in patients with metabolic dysfunction-associated steatohepatitis (MASH)
As shortages of GLP-1s have resolved and off-label usage has become increasingly common, a class of casual users has emerged not obese, not diabetic, not even overweight, and, often, not on the radar of doctors
Effects of GLP-1 and Incretin-Based Therapies on Gastrointestinal Motor Function